Ryo Sugiura

Dr. Ryo Sugiura

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2019 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
RSRyo Sugiura
Ryo Sugiura
Masaki KuwataniMasaki Kuwatani
Masaki Kuwatani
KHKoji Hirata
Koji Hirata
ISItsuki Sano
Itsuki Sano
SKShin Kato
Shin Kato
NSNaoya Sakamoto
Naoya Sakamoto

5 November 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
KNKosuke Nagai
Kosuke Nagai
Masaki KuwataniMasaki Kuwatani
Masaki Kuwatani
KHKoji Hirata
Koji Hirata
GSGoki Suda
Goki Suda
HHHajime Hirata
Hajime Hirata
NSNaoya Sakamoto
Naoya Sakamoto
Poor prognosis of pancreaticobiliary malignancies is attributed to intrinsic biological aggressiveness and the lack of reliable methods for early diagnosis. This study aimed to evaluate the feasibility and availability of pancreatic juice- and bile-derived cell-free DNA (cfDNA) for diagnosing pancreaticobiliary strictures. From October 2020 to February 2022, pancreatic juice or bile was obtained from 50 patients with pancreaticobiliary strictures during endoscopic retrograde cholangiopancreatography. cfDNAs extracted from the samples were analyzed using next-generation sequencing and a cancer gene panel. The obtained cfDNAs, genetic data and clinical information were analyzed for diagnosis. cfDNA concentrations in pancreatic juice were higher in the intraductal papillary mucinous neoplasm group than in the other groups, whereas those in bile were similar in all groups. In pancreatic juice, the sensitivity, specificity and positive and negative predictive values of cfDNA analyses were 33%, 100%, 100% and 71.4%, respectively, whereas those of cytological analyses were 0%, 100%, 0% and 62.5%, respectively. In bile, those of cell-free DNA analyses were 53%, 75%, 89.5% and 28.6%, respectively, whereas those of cytological analyses were 19%, 100%, 100% and 16%, respectively. In conclusion, pancreatic juice- and bile-derived cfDNA is a novel liquid biopsy tool that can diagnose pancreaticobiliary strictures.

17 December 2020 in Endoscopy
Verified
Journal Article
Closed access
PDF file
SMShuichi Miyamoto
Shuichi Miyamoto
RSRyo Sugiura
Ryo Sugiura
SASatoshi Abiko
Satoshi Abiko
KHKazuteru Hatanaka
Kazuteru Hatanaka
YYYoshiya Yamamoto
Yoshiya Yamamoto
NSNaoya Sakamoto
Naoya Sakamoto
Delayed bleeding is one of the postoperative complications of gastric endoscopic submucosal dissection (ESD) [1]. The clipping of exposed blood vessels after ESD completion is effective in preventing delayed bleeding [2] [3]. However, the exposed blood vessels are sometimes difficult to detect. Herein we report the effectiveness of a novel image-enhanced endoscopic technology called red dichromatic imaging (or dual red imaging) for detecting exposed blood vessels and preventing delayed bleeding after gastric ESD. A 61-year-old man had a 25-mm 0-IIc lesion located in the middle gastric body. We performed ESD using esophagogastroduodenoscopy (GIF-H290 T with EVIS X1 video system; Olympus Medical Systems, Tokyo, Japan). After completion of ESD, the scope was changed to a GIF-EZ1500, and the ESD-induced ulcer was observed ([Fig. 1 a], [Video 1]). We switched the white light imaging to red dichromatic imaging and the exposed blood vessels were more clearly visualized ([Fig. 1 b], [Video 1]). A blood vessel penetrating the muscle layer was covered with submucosal fibrous and fatty tissue, as observed by white light ( [Fig.2 a]). This blood vessel could be identified more clearly than the surrounding tissue using red dichromatic imaging ([Fig. 2 b]). We were able to easily detect the exposed blood vessels using red dichromatic imaging and then perform clipping (HX-610-090S; Olympus Medical Systems) ([Fig. 3]). The patient was discharged without delayed bleeding. Video 1 The observation of the exposed blood vessels in a gastric ulcer induced by endoscopic submucosal dissection using red dichromatic imaging. Red dichromatic imaging is a novel image-enhanced endoscopic technology using three wavelengths (540 nm, 600 nm, and 630 nm). Its effectiveness for detecting bleeding vessels has been previously reported [4]. In this case, submucosal fibrous tissue, fatty tissue, and the muscle layer were identified as a whiter collar using red dichromatic imaging rather than white light. Red dichromatic imaging helped gain a clear endoscopic view during colorectal ESD with submucosal fatty tissue [5]. We were able to easily detect the exposed blood vessels using red dichromatic imaging because the color difference between the exposed blood vessels and surrounding tissue was clear. Endoscopy_UCTN_Code_TTT_1AO_2AB Publication Date: 17 December 2020 (online) © 2020. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

26 January 2022 in Digestion
Verified
Journal Article
Closed access
PDF file
RSRyo Sugiura
Ryo Sugiura
MKMasaki Kuwatani
Masaki Kuwatani
THTsuyoshi Hayashi
Tsuyoshi Hayashi
MYMakoto Yoshida
Makoto Yoshida
HIHideyuki Ihara
Hideyuki Ihara
HGHokkaido Interventional EUS/ERCP study (HONEST) group
Hokkaido Interventional EUS/ERCP study (HONEST) group
Introduction: Preoperative endoscopic biliary drainage (PEBD) for malignant hilar biliary obstruction (MHBO) is widely accepted. Recent PEBD consists of endoscopic nasobiliary drainage (ENBD), conventional endoscopic biliary stenting (CEBS) with plastic stents across the papilla, and endoscopic biliary inside stenting (EBIS) with plastic stents above the papilla, while ENBD is the primary procedure in Asian countries. Thus, we aimed to compare the efficacy of ENBD with those of CEBS and EBIS as a means of PEBD for MHBO. Methods: We retrospectively identified patients with MHBO who underwent upfront surgery between January 2011 and December 2018 in a multicenter setting. The outcome measures were cumulative dysfunction of PEBD, risk factors for PEBD dysfunction, and adverse events. Results: We analyzed a total of 219 patients, comprising 163 males (74.4%); mean age, 69.7 (±7.6) years; Bismuth-Corlette (BC) classification I, II, IIIa, IIIb, and IV in 68, 49, 43, 30, and 29 patients, respectively; and diagnosis of hilar cholangiocarcinoma and gallbladder cancer in 188 and 31 patients, respectively. PEBD procedures were performed in 160 patients with ENBD, 31 patients with CEBS, and 28 patients with EBIS. PEBD dysfunction occurred in 58 patients (26.5%), and the cumulative dysfunction rates were not significantly different among PEBD methods (p = 0.60). Multivariate analysis showed that BC-IV was significantly associated with the occurrence of PEBD dysfunction (hazard ratio = 2.10, p = 0.02). The adverse event rates were not significantly different among PEBD groups (p = 0.70). Conclusion: ENBD as a means of PEBD for MHBO is comparable with CEBS and EBIS in rates of dysfunction and adverse events.

12 June 2022 in Pancreas
Verified
Journal Article
Open access
SNShintaro Nakano
Shintaro Nakano
YKYasuyuki Kawamoto
Yasuyuki Kawamoto
YKYoshito Komatsu
Yoshito Komatsu
RSRika Saito
Rika Saito
KIKen Ito
Ken Ito
NSNaoya Sakamoto
Naoya Sakamoto
Objectives: Most previous studies have analyzed bacteria in tumors using resected pancreatic cancer (PC) tissues, because it is difficult to obtain tissue samples from unresectable advanced PC. We aimed to determine whether minimal tissue obtained by endoscopic ultrasound–guided fine-needle aspiration is useful for microbiome analysis. Methods: Thirty PC and matched duodenal and stomach tissues (N = 90) were prospectively collected from 30 patients who underwent endoscopic ultrasound–guided fine-needle aspiration. Bacterial DNA was extracted, and 16S rRNA sequencing was performed. The primary outcome was the success rate of bacterial detection in tumors. Bacterial diversity and structure were investigated. Results: The bacterial detection rates were 80%, 100%, and 97% in PC, gastric, and duodenal samples, respectively. Pancreatic cancer tissues showed a lower α-diversity and a significantly different microbial structure than stomach and duodenal tissues. Proteobacteria were more abundant, whereas Firmicutes, Bacteroidetes, and Fusobacteria were less abundant in PC tissues than in stomach and duodenal tissues. Acinetobacter was more abundant in PC tissues than in stomach and duodenal tissues, and Delftia was more frequently detected in resectable PC. Conclusions: Endoscopic ultrasound–guided fine-needle aspiration samples were valuable for PC microbiome analysis, revealing that the bacterial composition of PC is different from that of the stomach and duodenum.

14 January 2021 in Endoscopy
Verified
Journal Article
Closed access
PDF file
SMShuichi Miyamoto
Shuichi Miyamoto
TOTomohiko R. Ohya
Tomohiko R. Ohya
KNKaori Nishi
Kaori Nishi
SASatoshi Abiko
Satoshi Abiko
RSRyo Sugiura
Ryo Sugiura
NSNaoya Sakamoto
Naoya Sakamoto
Endoscopic submucosal dissection (ESD) for gastric tumors is performed worldwide. When vascularized lesions are treated, hematoma in the submucosal layer is sometimes encountered during dissection. The presence of submucosal fibrosis and hematoma often makes dissection very difficult because identifying the correct submucosal tissue plane is almost impossible despite attempts at washing using the scope’s water jet function. Red dichromatic imaging (RDI; Dual Red Imaging) is a recently released novel image-enhanced endoscopic technology (Olympus Medical Systems, Tokyo, Japan) [1] [2] [3] [4]. We report a case in which RDI helped identify submucosal fibrous tissue in the submucosal layer with hematoma during gastric ESD. A 72-year-old man with a gastric tumor was referred to our hospital. ESD was performed using an electrosurgical knife (IT2 knife; Olympus Medical Systems) and therapeutic gastroscope (GIF-H290 T with EVIS X1 video system; Olympus Medical Systems). A circumferential incision was made and the submucosal layer subsequently dissected. However, the submucosal injection caused bleeding in the submucosal layer, leading to submucosal hematoma ([Video 1]; [Fig. 1]). In this situation, identifying the submucosal fibrous tissue for dissection under white light ([Video 1]; [Fig. 2 a]) was difficult. The white light imaging was then switched to RDI, and the submucosal fibrous tissue could be visualized more clearly ([Fig. 2 b]). The submucosal layer was dissected and the tumor finally resected en bloc. Video 1 Endoscopic submucosal dissection for gastric tumor in a 72-year-old man. The submucosal fibrous tissue could be identified more clearly in the submucosal layer with hematoma using red dichromatic imaging. In this case, the submucosal fibrous tissue was identified because it showed whiter using RDI than under normal white light imaging ([Fig. 3]), and the bleeding was visualized as yellow on RDI. Thus, the submucosal fibrous tissue could be identified through the hematoma, and was dissected despite the presence of the hematoma. Another advantage of RDI is that it keeps the endoscopic view clearer during ESD with submucosal fatty tissue [5]. We believe that RDI is useful for dissecting submucosal fibrous tissue in the submucosal layer with hematoma during gastric ESD. Endoscopy_UCTN_Code_CCL_1AB_2AD_3AF Publication Date: 14 January 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany